These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 19490203)
1. Ceftobiprole: a new beta-lactam antibiotic. Stein RA; Goetz RM; Ganea GM Int J Clin Pract; 2009 Jun; 63(6):930-43. PubMed ID: 19490203 [TBL] [Abstract][Full Text] [Related]
2. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin. Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975 [TBL] [Abstract][Full Text] [Related]
3. New and emerging treatment of Staphylococcus aureus infections in the hospital setting. Moreillon P Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():32-41. PubMed ID: 18318877 [TBL] [Abstract][Full Text] [Related]
4. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus. Jones ME Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006). Fritsche TR; Sader HS; Jones RN Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000 [TBL] [Abstract][Full Text] [Related]
11. Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). Barbour A; Schmidt S; Rand KH; Derendorf H Int J Antimicrob Agents; 2009 Jul; 34(1):1-7. PubMed ID: 19261449 [TBL] [Abstract][Full Text] [Related]
12. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Jorgenson MR; DePestel DD; Carver PL Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993 [TBL] [Abstract][Full Text] [Related]
13. Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Saravolatz LD; Stein GE; Johnson LB Clin Infect Dis; 2011 May; 52(9):1156-63. PubMed ID: 21467022 [TBL] [Abstract][Full Text] [Related]
14. Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA. Garrison MW; Kawamura NM; Wen MM Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1087-103. PubMed ID: 23167512 [TBL] [Abstract][Full Text] [Related]
15. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Poon H; Chang MH; Fung HB Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785 [TBL] [Abstract][Full Text] [Related]
16. MRSA--the tip of the iceberg. Appelbaum PC Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422 [TBL] [Abstract][Full Text] [Related]
17. Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens. Steed ME; Rybak MJ Pharmacotherapy; 2010 Apr; 30(4):375-89. PubMed ID: 20334458 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524 [TBL] [Abstract][Full Text] [Related]
19. Ceftobiprole: A novel, broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Dauner DG; Nelson RE; Taketa DC Am J Health Syst Pharm; 2010 Jun; 67(12):983-93. PubMed ID: 20516468 [TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials. Deresinski SC Diagn Microbiol Infect Dis; 2008 May; 61(1):103-9. PubMed ID: 18384998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]